UBR7 anticorps (N-Term)
Aperçu rapide pour UBR7 anticorps (N-Term) (ABIN630845)
Antigène
Voir toutes UBR7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- C14 ORF130 antibody was raised against the N terminal Of C14 rf130
-
Purification
- Affinity purified
-
Immunogène
- C14 ORF130 antibody was raised using the N terminal Of C14 rf130 corresponding to a region with amino acids MAGAEGAAGRQSELEPVVSLVDVLEEDEELENEACAVLGGSDSEKCSYSQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C14ORF130 Blocking Peptide, (ABIN5612407), is also available for use as a blocking control in assays to test for specificity of this C14ORF130 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C10 RF130 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UBR7 (Ubiquitin Protein Ligase E3 Component N-Recognin 7 (UBR7))
-
Autre désignation
- C14ORF130
-
Sujet
- C14ORF130 is an E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. C14ORF130 recognises and binds to proteins bearing specific amino-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation.
-
Poids moléculaire
- 48 kDa (MW of target protein)
Antigène
-